🔬 Current Disease Focus:
Task Progress: 0%
👥 Active Problem Solvers
0
🌍 Experts collaborating globally
⚡ Current Task Assignment
🧬 Genetic Analysis
🔄 Matching experts to specific tasks
📊 Resource Allocation by Research Phase:
📚 Data Analysis
🧪 Experimental Design
🔬 Clinical Trials
💊 Treatment Development
By 2030, the global prevalence of Alzheimer's Disease (AD) is predicted to ...
Status
Completed
Location
IRCCS Centro San Giovanni di Dio Fatebenefratelli
Start Date
2016-01
Trial ID
NCT03382353
A Randomized Clinical Trial that will compare the effects of Cannabidiol an...
Status
Unknown
Location
Greek Association of Alzheimer's Disease and Related Disorders
Start Date
2021-04-01
Trial ID
NCT05022186
Treatments Being Tested
the general purpose of the study is to evaluate the potential beneficial ef...
Status
Terminated
Location
Dario Sisto
Start Date
2018-01-25
Trial ID
NCT04422743
Treatments Being Tested
This study is being conducted to evaluate the safety and efficacy of ALZ-80...
Status
Completed
Location
Xenoscience
Start Date
2021-05-19
Trial ID
NCT04770220
Treatments Being Tested
Dosage of pro-inflammatory cytokines and soluble mediators (TNFα, IL6, IL2 ...
Status
Completed
Location
University of Molise
Start Date
2019-09-16
Trial ID
NCT04378972
Treatments Being Tested
Phase 1, single-center, open-label, non-randomized, sequential single dose ...
Status
Completed
Location
Multiple Locations
Start Date
2015-09-16
Trial ID
NCT04585347
Treatments Being Tested
The purpose of this Phase III open-label extension study is to evaluate the...
Status
Unknown
Location
San Francisco Clinical Research Center
Start Date
2006-05
Trial ID
NCT00314912
Treatments Being Tested
The goal of this clinical trial is to examine the effect of the fixed combi...
Status
Completed
Location
Clinica Oculistica Università Federico II
Start Date
2024-01-27
Trial ID
NCT06431113
Treatments Being Tested